As per an exhaustive study by FMI, the global Opioid Analgesics Market is anticipated to reach US$ 69.55 billion by 2032, from an estimated value of US$ 41.11 Billion in 2022.

In response to surging demand for post-surgery pain management and focus on novel drug formulations for analgesics, the market is estimated to expand at a CAGR of 5.4% over the forecast period 2021-2031, in comparison to the 4.2% CAGR registered from 2106 to 2020.

Opioid analgesics market is largely driven by the increasing prevalence of chronic disorders, neuropathic pain, and orthopedic diseases. Opioids are extensively used for anesthesia, cough suppression, cancer pain management, and treatment of several other conditions. In addition to this, the development of novel analgesics with fewer side effects is expected to spur sales by 1.7X through 2031.

A considerable rise in the number of surgical procedures has been reported in the last few years. According to the International Society of Aesthetic Plastic Surgery (ISAPS), around 11.3 million surgeries were reported across the world in 2019. As opioids are used as medications for managing and reducing pain post-surgeries, the surgical pain indication segment is anticipated to account for nearly 45.9% of the total sales by 2031. The growth in the region is attributed to the increasing prevalence of chronic diseases and presence of favorable medical reimbursement policies in the U.K and Germany.

“Commercialization of non-abusive opioids and increasing availability of opioid analgesics through online distribution channels are expected to accelerate the sales of opioid analgesics,” says the FMI analyst.

Key Takeaways from Opioid Analgesics Market Study

The U.S. is anticipated to lead the market in North America, accounting for nearly 86% of the overall sales in 2021.

Sales of opioid analgesics in Germany are estimated to total US$ 2.2 billion, growing at a CAGR of 3.8% during the assessment period.

The market in India is forecast to account for 35.4% of the sales in South Asia, expanding at a CAGR of 5.7% between 2021 and 2031.

China is expected to emerge as the most lucrative market for opioid analgesics in East Asia, contributing around 54.2% of the sales revenue in the region by 2021 end.

Among drug class verticals, oxycodone is estimated to dominate the segment accounting for more than 19% of the global demand in 2021.

Key Drivers

Surging demand for facial and body aesthetics in response to the rising number of aesthetic surgical procedures such as breast implantation, eyelid surgeries, and abdominoplasty conducted worldwide will spur the sales across surgical pain segment.

Increasing adoption of opioid maintenance treatment (OMT) for treating opioid dependence (OD) across Germany, the U.K., the U.S., and others are anticipated to drive the market growth.

Key Restraints

Side effects associated with opioid analgesics such as drowsiness, nausea, constipation, clouded thinking, and psychological & physical addiction are hampering the market growth.

Stringent government regulation and guidelines regarding manufacturing, storage, marketing, and selling of opioid products are restraining the growth of opioid analgesics.

Competitive Analysis:

Leading manufacturers are emphasizing on launching new and revised products to enhance their product portfolios. Strategies such as product approvals, partnerships, agreements, merger, facility expansion, and collaborations are expected to assist market players strengthen their footprint and gain a competitive edge over other players. For instance,

In May 2020, Assertio Therapeutics, Inc., an American specialty pharmaceutical company, announced entering into merger agreement with a U.S.-based pharmaceutical company, Zyla Life Sciences. The merger will assist companies to expand their product portfolio of inflammation, neurology, and chronic pain medications.

In September 2018, Novartis, a Swiss multinational pharmaceutical corporation, announced signing an agreement for marketing, distribution, and sales, of well-known pain medicine brands such as Cataflam (diclofenac potassium) and Voltaren (diclofenac sodium) in Thailand, Malaysia and Philippines.

Pfizer Inc.

Abbott Laboratories

Janssen Pharmaceuticals, Inc. [Johnson & Johnson]

Novartis AG

Bayer AG

GlaxoSmithKline plc

F. Hoffmann-La Roche AG,

Boehringer Ingelheim International GmbH

Bausch Health Companies Inc.

Sanofi S.A.

Teva Pharmaceuticals

AbbVie Inc. (Allergan plc)

Purdue Pharmaceuticals L.P.

Sun Pharmaceutical Industries Ltd.

Mallinckrodt Pharmaceuticals

Endo Pharmaceuticals Inc. [Endo International plc]

Assertio Therapeutics, Inc. [Assertio Holdings, Inc.]

Opioid Analgesics Market Segmentation:

By Drug Class:

Morphine

Codeine

Fentanyl

Meperidine

Methadone

Tramadol

Oxycodone

Dextromethorphan

Buprenorphine

Others

By Indication:

Surgical Pain

Cancer Pain

Neuropathic Pain

Other

By Route of Administration:

Oral

Parenteral

Transdermal

Other

By End User:

Hospitals

Retail Pharmacies

Drug Stores

Online Pharmacies

By Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

MEA

For More Information: https://www.futuremarketinsights.com/reports/opioid-analgesics-market

The physiotherapy equipment market is estimated to record a healthy growth, exhibiting a CAGR of 7.7% in the forecast period between 2022 and 2032. Musculoskeletal physiotherapy will remain a key contributor to revenue generated in the market. Besides this, surging cases of orthopedic disorders in North America and East and South Asia are expected to fuel demand for physiotherapy equipment.

Physiotherapy Equipment Market Dynamics:

In a recent study published by the World Health Organization, over a billion adults are observed to live a sedentary lifestyle. They remain inadequately active at all times. High-stress levels from professional and personal responsibilities are the major causes of lethargy, thus leading to various orthopedic disorders.

Moreover, with the increase in pollution, people are often neglecting outdoor sports or activities, thus adding to the reduced levels of physical exertion. This has resulted in the weakening of bones and frozen joints that require immediate physiotherapy attention. Devices such as pain relievers, braces, and so on are widely being used to prevent physical injuries.

In another report, musculoskeletal disorders enclose over 150 diagnoses related to a person’s bones, muscles, tendons, joints, or ligaments. This includes short-term fractures or long term pain or disability. These conditions affect both the geriatric and the young generations thereby limiting their mobility. This is harming individuals who are considering early retirement, inability to fulfill social responsibilities, and reduced income. Thus, the demand for sophisticated treatment has provided the leading market players to manufacture technologically advanced physiotherapy units.

Impact of COVID-19 Pandemic In The Physiotherapy Equipment Market

The impact of the COVID-19 pandemic on a global scale has affected almost every type of industry. Healthcare industries mainly responsible for quick treatment of coronavirus patients and also preventing the spread of the virus have reported some benefits, unlike the other industries.

Physiotherapy is one such industry that faced a major decline in the global pandemic era. Physiotherapy is a branch of healthcare that demands patients to be in touch with their doctor to receive the necessary treatment. This makes patients extremely vulnerable to various communicable diseases. And one of the most contagious ones is the coronavirus itself. As the spread of coronavirus was due to physical contact, most physiotherapists opted to suspend their operations. This resulted in delays in procedures and thus the demand for physiotherapy equipment dropped rapidly.

Moreover, governments all over the world imposed strict lockdown rules that compelled people to stay indoors and halt industrial operations. This disrupted the global supply chain of physiotherapy equipment production because of the limited availability of raw materials.

What Is The Regional Distribution Of The Physiotherapy Equipment Market?

The key regions dominating the physiotherapy equipment market are North America, South America, Europe, East, and South Asia, Oceania, and the MEA (the Middle East and Africa).

Due to the rapidly growing population, South and East Asia are slowly coming to dominance with over 25% of the total revenue of the physiotherapy equipment market. The ultrasound equipment will be the emerging trend in potential cash flow. The North American market will continue to dominate the market holding a value of 40% and more.

Physiotherapy Equipment Market Competitive Landscape:

The physiotherapy equipment market is dominated by a few leading players. These are DJO Global, Enraf-Nonius, Kindred Healthcare, Inc., Select Medical, Concentra Operating Corporation, BTL Industries, U.S Physical Therapy, Inc., Isokinetic, Inc., EMS Physio Ltd and Zynex Medical Inc. These industries have been successful in recovering the current state of the market through new products, acquisitions, and improved marketing strategies. Recently, these companies have adopted Artificial Intelligence to mold their business practices following the post-pandemic situation.

Key Segments Covered:

Equipment Type:

Cryotherapy

Hydrotherapy

Electrotherapy

Continuous Passive Motion Units

Multi-exercise Therapy Unit

Heat Therapy

Ultrasound Physiotherapy

Other Therapy Types

Application:

Neurological

Musculoskeletal

Cardiovascular and Pulmonary

Others

End-user:

Hospitals

Rehabilitation Centers/Clinics

Homecare Settings

For More Information: https://www.futuremarketinsights.com/reports/physiotherapy-equipment-market

According to a study created by Future Market Insights (FMI), the market for blood warmer devices is anticipated to develop steadily. The market is estimated to generate US$ 223.5 million in revenue by the end of 2026.

The latest report compiled by Future Market Insights (FMI) provides insights and segment-wise analysis on the global blood warmer devices market. The report titled ‘Blood Warmer Devices Market': Global Industry Analysis 2012-2016 & Opportunity Assessment 2017-2026,’ also offers detailed analysis on the factors contributing towards the market growth. The primary objective of the report is to provide market dynamics including trends, drivers, opportunities, and restraints for both service providers and manufacturers. The blood warmer devices market has been studied in detail and forecast on regional and global growth has been presented including revenue, market size, CAGR, etc. The report also offers information on the overall market growth and key industry developments.

The report provides an executive summary which is followed by the brief introduction of blood warmer devices. Along with the 360-degree view of the market, the report focuses on key industries and competitors in the global blood warmer devices market. The report offers numbers that are based on the historical data and the forecast period. Data provided in the report is based on various parameters playing a crucial role in the market development. Considering the wide scope of the global blood warmer devices market, the report provides in-depth analysis and forecast on various segments. The global blood warmer devices market is segmented into product type, end user, application, and region. The segmentation also offers country-wise analysis and forecast on the basis of key parameters in the market.

Blood Warmer Devices Market Segmentation:

By Product Type

Intravenous Warming System

Surface Warming System

Blood Warming Accessories

By Application

Preoperative Care

Home Care

Acute Care

New Born Care

Other Applications

By End-user

Hospitals

Blood Banks

Home Care Settings

Other End-users

By Region

North America

Latin America

Europe

Japan

APEJ

MEA

Providing a detailed description of all the segments, the report also offers information on the stages through which the blood warmer devices passes before reaching the end user. These stages include raw material supplier, manufacturer, transportation, etc., although these stages differ depending on the product. All the key metrics including year-on-year growth, absolute dollar opportunity, CAGR, basis point share, revenue, and market attractiveness index has been provided in the report. Key trends in the report offer the clear picture on the market, latest developments, etc. The report also talks about the innovative technologies and advanced features in blood warmer devices. The market attractiveness analysis gives an idea of the most dominating segment based on trends and forecast. The report also offers Porter’s five force analysis and SWOT analysis to determine a current scenario in the market.

Key Market Players:

The leading players in the global market for blood warmer devices are -

Smiths Medical

3M Company

The 37 Company

Emit Corporation

GE Healthcare

Stryker Corporation

Barkey GmbH & Co. KG

Geratherm Medical

Stihler Electronic GmbH

Belmont Instrument

Biegler GmbH

Baxter International Inc. (Gambro)

Keewell Medical Technology Co. Ltd.

Research Methodology

All the microeconomic and macroeconomic factors have been taken into account determine market numbers. The global blood warmer devices market size has been analyzed with the help of primary and secondary research. In order to determine the market size, the revenue of all the key players currently active in the market has been benchmarked. Various factors were being considered to determine the market size during the forecast period 2017-2026.

The report also offers vital information on the key market players based on various parameters such as financial overview, strategies, company overview, product portfolio, and new developments.  These players are adopting various strategies in order to survive in the market and compete. The region-wise segmentation includes Europe, Latin America, North America, Japan, Asia Pacific Excluding Japan (APEJ), and the Middle East and Africa (MEA). Various tools have been used to validate the information and gather data and offer market insights on the global blood warmer devices market.

For More Information: https://www.futuremarketinsights.com/reports/blood-warmer-devices-market

The flow cytometry market is expected to grow at an CAGR of 9.5% from 2022 to 2032.

Flow cytometry is used to monitor microscopic particles with the help of electronic devices called flow cytometers. Flow cytometry is used in stem cell research, in the development of immunology products and vaccines and also in CD4 testing. The global flow cytometry market is influenced by various factors such as medical and technological developments in flow cytometry products, rising use of flow cytometry in clinical trials, in detection of blood cancer, in research, in launching of new reagents for critical applications such as drug discovery and diagnostics and also in development of intuitive and user-friendly software are fueling the growth of the flow cytometry market in the forthcoming timeline.

Moreover, rising prevalence of AIDS and cancer has triggered the adoption of flow cytometry technology in scientific research. This is supporting the growth of the global flow cytometry market.

Flow Cytometry Market Segmentation:

By Product Type:

Instruments

Reagents & Consumables

Software

Accessories

Services

By Application:

Research

Clinical

Industrial

By Technology:

Cell-based

Bead-based

By End User:

Commercial Organizations

Academic Institutes

By Region:

North America

Latin America

Europe

Japan

APEJ

MEA

Key Highlights on the Flow Cytometry Market Study

The global flow cytometry market is segmented by application, end user, technology, product type and region.

By application, the research segment is expected to dominate the global market with respect to high market share. By the end of 2022, this segment is estimated to reach a high market valuation of around US$ 1.8 Bn growing at a high CAGR during this period. The industrial segment is projected to grow at the highest rate during the assessment period and poised to gain a high BPS by the end of 2022.

By technology, the cell based segment is the largest segment. It is projected to grow at a CAGR of 7.2% throughout the period of forecast and is estimated to gain a very high valuation during the period of assessment.

North America region is a highly lucrative region for the growth of the global flow cytometry market. The market in North America is soaring at a higher pace and expected to surpass other regions.

By end user, the commercial organizations segment is expected to gain the highest BPS by end of 2022. Moreover, this segment demands increasing use of flow cytometry and is the largest and the fastest growing segment in the flow cytometry market.

In the product type category, the reagents and consumables have gained high traction in the recent years. This segment is a high contributor of growth of the global flow cytometry market. The reagents and consumables segment is estimated to gain a high BPS and grow at a high CAGR of 7.9% throughout the period of assessment.

Flow Cytometry Market: Competitive Landscape

The global flow cytometry market research study includes a separate section on competitive landscape in which it focuses on the key players and their in-depth analysis including company overview, SWOT analysis, developments, innovations, key financials and product portfolios.

Key Players:

Danaher Corporation

Becton Dickinson and Company

Sysmex Corporation

Agilent Technologies, Inc.

Merck & Co Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific, Inc.

Luminex Corporation

General Electric Company

Miltenyi Biotec GmbH

Others

For More Information: https://www.futuremarketinsights.com/reports/flow-cytometry-market

[250 Pages Report] The body contouring market is anticipated to grow at a CAGR of 6.9% from 2022 to 2032, rising from a valuation of US$ 7.3 billion in 2022 to US$ 11.1 billion by 2032.

The team of analysts at Future Market Insights are focusing on research and market study to produce different Body Contouring Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Body Contouring Market.

Key Market Segmentation Analysis:

By Invasiveness:

Non-Invasive Contouring

Minimally Invasive Contouring

Invasive Contouring

By End-user:

Hospitals

Ambulatory surgical centers

Medical Spa

Clinics

By Regional Covered:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Europe (Germany, Italy, France, U.K, Spain, , Russia)

East Asia (China, Japan, South Korea)

South Asia (India, ASEAN)

Oceania (Australia, New Zealand)

Middle East and Africa (GCC Countries, South Africa, Northern Africa)

Important changes in Market Dynamics:

The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.

Segmentation details of the market

Former, on-going, and projected market analysis in terms of volume and value

Assessment of niche industry developments

Market share analysis

Key strategies of major players

Emerging segments and regional markets

Key Market Companies Profiles:

GlobalMed Technologies

Chromogenex

Human Med.

Wells Johnson Company

Invasix Aesthetic Solutions

Erchonia

Fotona

Cutera

BTL Industries

Meridian

Palomar Medical Technologies

Others

For More Information: https://www.futuremarketinsights.com/reports/body-contouring-market

Poultry diagnostics market size is estimated to grow at an impressive CAGR of 10.5% from 2022 to 2028, and rise from a market valuation of US$ 495.2 Million in 2022 to US$ 1.1 Billion by 2028.

Widespread outbreaks of infectious diseases such as avian influenza is a key factor driving the demand for diagnostic infrastructure in the poultry industry. Also, awareness campaigns by public and private bodies about avian diseases among poultry farmers is positively influencing the industry.

Furthermore, concerns over food security and investments by governments and international bodies towards the intensive farming sector will drive cultivation of poultry. This will also support the demand for poultry diagnostics in the long-term.

Key Takeaways

ELISA tests are expected to continue holding major market share through 2030, owing to superior accuracy and cost efficiency.

Diagnostics for avian influenza has been estimated to reflect higher market share on the back of widespread incidences in developing countries.

Newer ailments such as mortality syndrome are expected to generate lucrative opportunities in terms of product development and interest from the veterinary sector.

Virology services are expected to be a major contributor to the market owing to higher risk from viral infections for human consumers.

South Asia & Pacific, will reflect fast growth, with poor hygiene standards in developing nations. North America will continue to hold larger market share, owing to superior infrastructure.

Insights on the Coronavirus Impact

As the covid-19 outbreak continues to wreak havoc on the global economy, the poultry diagnostics market is expected to also be adversely impacted during the crisis period. While chickens and other poultry birds are not at risk to the virus, the pandemic is likely to hurt consumption, logistics, and sales of birds. This can be largely attributed to strict regulations on the food service businesses.

These factors are expected to reduce chicken stocks in the poultry industry for the short term, which in turn will reduce the demand for diagnostic tools and infrastructure in the industry. The market is likely to recover strongly towards 2021, as demand for poultry products picks up. Strict food safety laws and concerns over other strains of coronavirus will aid market developments.

Competition Analysis:

Market leaders in the poultry diagnostic industry include but are not limited to

Agrobiotek Internacional

Affinitech Ltd.

Biochek

Bioingentech Biotechnologies Inc.

Bionote Inc.

Boehringer Ingelheim GmbH

GD Animal Health

Idexx Laboratories Inc.

IDVet

Megacor Diagnostik GmbH

Qiagen N.V.

Thermo Fisher Scientific

Zoetis Inc.

Bioneer Corporation

Market participants are increasingly focused on the product research with the aim of developing and launching improved testing tools for faster and accurate results. In addition, strategic industry collaborations and acquisitions are being used to build a foundation in a moderately competitive landscape.

Poultry Diagnostics Market Segmentation:

By Test:

ELISA Test

PCR Test

By Disease:

Avian Salmonellosis

Avian Influenza

Newcastle Disease

Avian Mycoplasmosis

Avian Pasteurellosis

Infectious Bronchitis

Infectious Bursal Disease

Avian Encephalomyelitis

Avian Reovirus

Chicken Anemia

By Service:

Bacteriology

Virology

Parasitology

By Region:

North America

Europe

APAC

ROW

For More Information: https://www.futuremarketinsights.com/reports/poultry-diagnostics-market

The advanced wound care market, which had a value of US$10.3 billion in 2020, is anticipated to grow at a CAGR of 3.7% during the forecast period (2021-2031). According to a Future Market Insights (FMI) analysis, it is anticipated to produce US$ 15.4 Billion in sales by the end of 2031.

Advance Wound Care Market - Competition Analysis

The market is consolidated and key market players that dominate the market are

B.Braun Melsungen AG

Mölnlycke Health Care

ConvaTec Group plc

Coloplast A/S

Johnson and Johnson

Medline Industries Inc.

3M

Others

Advanced Wound Care Market Summary:

The Advanced Wound Care Market research discusses the market’s upcoming problems and possibilities. By offering all of the crucial facts linked to market growth, the study ensures a reinforced position in the industry and a rising product portfolio.

The Advanced Wound Care market research report also includes some crucial insights and discusses the influence of the COVID-19 situation on several economic sectors. The most significant component in improving and increasing profitability is identifying crucial company areas.

This data-rich market research gives you a better idea of how new product offerings might fit into the market. In practically every point of the business cycle, it serves as the best guide and takes the lead.

The report makes it simple to target customers and easily promote new items. Another essential aim, according to this Advanced Wound Care market, is to give manufacturing solutions at all provincial and global levels.

This Advanced Wound Care market research study gives a thorough review of market conditions and numerous business-related aspects.

The report helps business operators to reach out to specific target groups and includes all pertinent information about consumers and competitors.

To give reliable market data and problem-solving, this market research use quantitative research approaches. The Advanced Wound Care Market research assists in identifying key regions such as Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America where new businesses and merchants can extend their operations. It also conducts in-depth research and reports on market size, market dynamics, and market share.

Global Advanced Wound Care Market: Dynamics

The research report includes an examination of many aspects that contribute to the market’s expansion. It consists of market trends, restraints, and drivers that have a positive or negative impact on the market.

This section also discusses the many sectors and applications that may have an impact on the market in the future.

The data is based on current trends as well as historical milestones. This section also includes a study of worldwide production volume and production volume by type from 2021 to 2031.

From 2021 to 2031, the volume of output by region is discussed.

Advance Wound Care Market Segmentation:

By Product:

Hydrogels DressingsAntimicrobial Hydrogel Dressings

Non-Antimicrobial Hydrogel Dressings

Semi-Permeable Films Dressings

Semi-Permeable Films DressingsAntimicrobial Bordered Film Dressings

Antimicrobial Non-Bordered Film Dressings

Semi-Permeable Films DressingsNon Antimicrobial Bordered Film Dressings

Non Antimicrobial Non Bordered Film Dressings

Alginate DressingsAntimicrobial Alginate Dressings

Non Antimicrobial Alginate Dressings

Foam Dressings

Antimicrobial Foam DressingsAntimicrobial Bordered Foam Dressings

Antimicrobial Non Bordered Foam Dressings

Non Antimicrobial Foam DressingsNon-Antimicrobial Bordered Foam Dressings

Non-Antimicrobial Non- Bordered Foam Dressings

Hydrocolloid DressingsAntimicrobial Hydrocolloid Dressings

Non Antimicrobial Hydrocolloid Dressings

Collagen DressingsAntimicrobial Collagen Dressing

Non Antimicrobial Collagen Dressing

Contact LayerAntimicrobial Wound Contact Layers

Non Antimicrobial Wound Contact Layers

Super Absorbent DressingsAntimicrobial Super Absorbent Dressings

Non Antimicrobial Super Absorbent Dressings

Compression System2 Layer Compression System

3 Layer Compression System

4 Layer Compression System

Antimicrobial Gels

Antimicrobial Powder

Concentrated Surfactant

Skin Protectants

Wound Cleansers

Honey Dressings

Unna Boots

Tapes

By Distribution Channel:

Institutional SalesHospitals

Long Term Care Centers

Retail Sales

By Region:

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa (MEA)

For More Information: https://www.futuremarketinsights.com/reports/advance-wound-care-market

Global biopharmaceutical contract manufacturing market is estimated to be worth US$ 9.3 billion in 2022 and is expected to grow at a CAGR of 10.5% to cross US$ 18.7 billion by 2029.

Reduced overall time to market investment in new drugs, access to expensive technologies, and greater flexibility are some advantages offered by biopharmaceutical manufacturing companies. On the back of these factors, several large companies have outsourced their biopharmaceutical manufacturing operations. Biopharmaceutical contract manufacturing is highly preferred among biopharmaceutical companies with limited in-house production capacity.

Pharmaceutical companies mainly focus on core areas of competence, and hence, do not prefer to take financial risks in the event of formulating the final dose of medicines. This is anticipated to accelerate the growth of the global biopharmaceutical contract manufacturing market during forecast period, estimated to be valued at US$ 18.7 Bn by 2029.

Biopharmaceutical Contract Manufacturing Market Segments:

By Platform Type:

Mammalian Based

Microbial Based

By Product Type:

Monoclonal Antibodies

Recombinant Protein

Vaccine

Insulin

Growth factor

Interferons

Others

By Application Type:

Clinical

Commercial

By Therapeutic Area Type:

Autoimmune Diseases

Oncology

Metabolic Diseases

Ophthalmology

Cardiovascular Diseases

Infectious Diseases

Neurology

Respiratory Disorders

Others

By Region:

North America

Latin America

Western Europe

Eastern Europe

APEJ

Japan

Middle East and Africa (MEA)

Regional Insights:

The U.S. dominates the North American region with a total market share of 91.0% in 2021 and is projected to continue experiencing high growth throughout the forecast period.

Germany is set to exhibit a CAGR of over 11.5% in the European biopharmaceutical contract manufacturing market during the forecast period. In this region, the next generation therapy market is believed to be driven by biological treatment options compared to the pharmaceutical option.

China holds 34.8% share in the East Asia market in 2021 and is projected to increase at a CAGR rate of 13.5% during the forecast period. The growth of the biopharmaceutical contract manufacturing market in the country is growing because, most of the pharma and biopharma companies are focusing to capitalize on the growth.

Asia Pacific is gaining attention among manufacturers for biologics production at reduced manufacturing cost. Emerging regions offering greater profit margins are major focus points for biopharmaceutical contract manufacturing, globally.”

Key Market Players:

Catalent Inc.

Lonza Group Ag

Patheon N.V. (Thermo Fisher Scientific Inc.)

Abzena Plc.

Sandoz International GmbH (Novartis AG)

Fujifilm Diosynth Biotechnologies (FUJIFILM Holdings)

Baxter Pharmaceutical Solutions LLC (Baxter Inc.)

AbbVie Contract Manufacturing (AbbVie Inc.)

Samsung Biologics Co. Ltd.

ProBioGen AG

Pfizer Centre Source Ltd (Pfizer Inc.)

Novasep

Biomeva GmbH

Kbi Biopharma Inc

Rentschler Biotechnologie GmbH

Ajinomoto Althea Inc. (Ajinomoto Co., Inc.)

Key Takeaways of Biopharmaceutical Contract Manufacturing Market Study

Although microbial-based platforms are abundantly used for the production of pharmaceuticals, mammalian-based cell culture is expected to gain traction during the forecast period, owing to higher efficiency and increasing demand.

In terms of product type, monoclonal antibodies currently hold a larger share of the biopharmaceutical contract manufacturing market, due to their superior efficacy as well as increasing adoption for the treatment of chronic diseases.

North America is anticipated to be the most lucrative region in the global biopharmaceutical contract manufacturing market, offering growth opportunities to market players.

The commercial application of biopharmaceutical contract manufacturing is expected to contribute a higher share as compared to clinical application by the end of 2029.

For More Information: https://www.futuremarketinsights.com/reports/biopharmaceutical-contract-manufacturing-market

The operating room equipment market is anticipated to grow at a CAGR of 4.5% over the course of the forecast period, from a valuation of US$ 30.9 Billion in 2020 to US$ 42 Billion in 2027.

Researches at FMI have no left no stone unturned in bestowing readers a comprehensive view of the market, by studying the drivers, trends, challenges, and restraints. Backed by historical data and projected data, the report breaks down the vast study into numerous geographies and end-use segments, among others to condense the research. The report also considers production and consumption analysis, value chain analysis, key findings, important suggestions and recommendations, and other aspects. Analysts at FMI have employed in-depth analysis to offer a lucid understanding of the market and the factors shaping its growth trajectory.

Ranging from macro socio-economic factors to micro geography-specific trends, the research has taken into consideration every facet that is likely to play a vital role in the growth of the market in the years to come. Presenting a plethora of valuable information, the report will serve as an effective tool, guiding the market players in making fruitful decisions in the forthcoming years.

Impact of COVID-19 on Operating Room Equipment Market

The unforeseen outbreak of COVID-19, which swiftly metamorphosed into the pandemic of unexpected proportions, has shifted the world’s focus towards the healthcare sector. National governments are closely working with healthcare institutions and pharmaceutical companies to provide effective treatment to patients suffering with the infection. As a result, there has been a reorientation of medical priorities across healthcare institutions with treatment for COVID-19 patients being the utmost priority.

This is sure to impact the growth of the Operating Room Equipment market through the pandemic period. FMI’s report includes a dedicated section expounding both the short-term and long-term impact of the pandemic on the Operating Room Equipment market. The study is shaped to bolster stakeholders in making the right decisions to mitigate challenges and leverage opportunities through the pandemic.

Operating Room Equipment Market: Key Segmentation

By Type:

Anesthesia Machines

Electrosurgical Devices

Multi-parameter Patient Monitors

Surgical Imaging Devices

Operating Tables

Operating Room Lights

Surgical Navigation Systems

By End User:

Hospitals

Outpatient Facilities

Ambulatory Surgical Centers (ASCs)

By Region:

North America

Latin America

Asia Pacific

MEA

Europe

Operating Room Equipment Market: Competition Analysis

The study bestows valuable insights into the competitive landscape of the global Operating Room Equipment market, by studying numerous players, their growth strategies, and key developments. The report dwells deep and studies different facets such as product launches, production methodologies, and steps adopted by players to make processes cost-effective, among others, are expected to influence their individual standpoint. Understanding the prevailing trends and strategies on the supply-side empowers players to foster their plan of action accordingly to progress on a remunerative path. Key players covered in the research include:

STERIS Corporation

Getinge AB

Stryker Corporation

Trumpf Medical

Creative Health Tech Pvt. Ltd.

Siemens Healthcare GmbH

Others

For More Information: https://www.futuremarketinsights.com/reports/operating-room-equipment-market

As per the latest report published by Future Market Insights, the Real World Evidence Solutions Market was valued at US$ 39.2 Billion in 2021 and is anticipated to reach the valuation of US$ 110 Billion by the end of 2032, growing at a CAGR of 10%.

The compound annual growth rate for the forecasted period is significantly higher from the historical CAGR of 8.6%. Furthermore, the market is expected to witness an absolute dollar opportunity of US$ 67.2 in the coming 10 years.

Services category is expected to garner an absolute dollar opportunity of US$ 41 Bn during 2022 – 2032. During this period, the services segment is projected to account for the majority share in the global market and is predicted to increase at a compound annual growth rate of 10.4%.  The pharmaceutical and biotechnology industries are driving market expansion by increasing their use of real-world services. Among these segments, the clinical data collected during ongoing patient treatment or as a part of a formal clinical trial program is a common source of information in most medical studies.

There can be seen a shift from volume-based to value-based care, favorable policies from the government, increasing R&D expenditure and a growing focus on end-to-end RWE services, which are driving the global market. By the end of 2032, the Global Market for Real World Evidence Solutions will show a valuation of US$ 110 Bn. Furthermore, a growing emphasis on personalized healthcare, increase in the frequency of chronic diseases, growing geriatric population, and regulatory support for the implementation of RWE solutions are expected to drive market expansion.

Key Takeaways from the Market Study:

The Market is expected to grow at a CAGR of 10% which is significantly higher than its historical CAGR of 8.6%.

By the end of 2032, the global market for Real World Evidence Solutions will reach the valuation of US$ 110 Bn.

Within the period between 2022 and 2032, the market is expected to offer an absolute dollar opportunity of US$ 67.2 Bn.

The services segment leads the growth among components with a CAGR of 10.4%.

The U.S. market for Real World Evidence Solutions constitutes a majority stake of 29.9% in the global market. It is expected to grow at a CAGR of 11.2% during the forecasted period of 2022 to 2032.

Drug Development and Approvals segment tops among the applications. Revenue through this segment is expected to grow at a CAGR of 10% during the forecast period.

Due to the pandemic induced business disruptions, companies were unable to undertake on-site surveillance or deliver services that required one to one interactions. This prompted the market players to implement several cost-cutting measures and business continuity tactics to allow remote access and monitoring of patients, comments a Future Market Insights analyst.

Real World Evidence Solutions Market Segmentation:

By Component:

Services

Data SetsClinical Settings Data

Claims Data

Pharmacy data

Patient-powered Data

By Application:

Reimbursement/Coverage & Regulatory Decision Making

Drug Development & Approvals

Medical Device Development & Approvals

Post Market Safety & Adverse Events Monitoring

By End-user:

Healthcare payers

Pharmaceutical & Medical Device Companies

Healthcare Providers

Other End-users

By Region:

North AmericaU.S.

Canada

Latin AmericaBrazil

Mexico

Others

EuropeGermany

U.K.

France

Spain

Italy

Russia

Others

APACIndia

China

Japan

South Korea

Australia

Others

MEASouth Africa

Saudi Arabia

UAE

Israel

Others

Competitive Landscape:

The Real World Evidence Solutions Market is driven by the Market players who are expanding their product portfolios by highly investing in the R&D and Product development areas. Furthermore, to retain their dominance in global market they are expanding by means of strategic mergers and acquisitions and creating the market presence in the untapped market across the globe. They are anticipated to take advantage of the increased awareness, improved infrastructure and increased regulatory approvals for the RWE solutions.

The key competitors in the real world evidence solutions market are –

Cegedim Health Data

IBM

Icon Plc.

IQVIA

Medpace

Oracle

Parexel International Corp.

PerkinElmer, Inc.

PPD, Inc.

Syneos Health

Key developments in the Real World Evidence Solutions Market:

• In March 2022, the collaboration between Thermo Fisher and Symphogen has been expanded to include improved data workflow, which aids in the discovery and development of innovative cancer treatments.

• In February 2021, IBM begins the second phase of a contract with the National Institutes of Health to develop a verifiable health status reporting and contact tracing system.

• In January 2022, IQVIA partnered with Argenex SE for accelerating the clinical development of new indications for VYVGART. Furthermore, it will leverage its scientific advice and technology in supporting clinical development by Argenx.

For More Information: https://www.futuremarketinsights.com/reports/real-world-evidence-solutions-market